Omnipod® 5 Pro Tip Series
Hosted by the Juicebox Podcast
Check out our three-part series on the Juicebox Podcast for tips on getting the most out of your Omnipod® 5 experience!
Juicebox Podcast host Scott Benner and guest Cari Berget talk through the features of the Omnipod 5 Automated Insulin Delivery System, answer listener questions and give plenty of tips to help you get the most from Omnipod 5 Pod Therapy.
Before you press play, it is important to note that these episodes were initially made for the US audience and that there are some differences between Omnipod 5 functionality in the US and other countries.
Please bear in mind:
- You cannot self-start Omnipod 5 in the UK. Please contact your healthcare team to discuss suitability for Omnipod 5
- Measurements for blood glucose levels in the USA are different from in the UK. For example, when the USA presenter mentions a value like 110mg/dL, it equates to a value of 6.1 mmol/L in the UK. (This value is reached by dividing 110mg/dL by 18.02 to get 6.1mmol/L).
- In the UK, the Omnipod 5 app is available only on an Insulet-provided controller. Omnipod 5 setup, settings, bolus doses and more are managed by you using the Controller, not a compatible smartphone.
- Content provided in this podcast is not intended and should not be construed as medical advice, nor is the information a substitute for professional medical expertise or treatment.
- Please speak with your healthcare team about any medical concerns and before making any changes to your diabetes management.
Click here for further UK specific resources and information on Omnipod 5.
Episodes
Episode 1: Overview
All of your questions about SmartAdjust™ technology answered, including how to prepare for training, what to expect with your first few Pods, and tips for ongoing success.
- 5:58 – What you need to get started
- 11:30 – Optimizing your initial settings
- 16:37 – Total Daily Insulin and why it matters
- 24:55 – What to expect with your first Pod
- 1:04:40 –Settings adjustments to consider as you get started
Episode 2: Settings
A review of the Omnipod 5 System settings to help you understand what each means and how they affect your insulin delivery.
- 3:59 – Basal settings including initial Basal Program and Maximum Basal Rate
- 11:19 - Target Glucose and Correct Above
- 20:03 – Bolus settings including Insulin to Carb Ratio and Correction Factor
Episode 3: Connectivity
All about the Omnipod 5 System’s integration with the Dexcom G6 Continuous Glucose Monitor and how you can maximize time spent in Automated Mode.
- 2:25 – Keeping your Pod and Dexcom within line of sight
- 5:05 – Automated Mode Limited
- 8:34 – Automated Delivery Restriction Alarms
- 20:59 – Activity feature
Insulet Corporation is not affiliated, endorsed, or otherwise associated with the Juicebox Podcast. Insulet has paid a fee to the host of this podcast, Scott Benner, and his guest speaker, Cari Berget, to create this content. Insulet also has an ongoing commercial relationship with both Scott and Cari.
UK RISK STATEMENT HERE
Important Safety Information: Omnipod® 5 System safety and intended use information.
The Omnipod 5 System is indicated for use by individuals with type 1 diabetes mellitus in persons 2 years of age and older. The Omnipod 5 System is intended for single patient, home use and requires a prescription and/or ongoing supervision of a qualified healthcare professional. The Omnipod 5 System is compatible with the following U-100 insulins: NovoLog(R)/NovoRapid(R).Humalog®, and Admelog(R)/Insulin lispro Sanofi(R). The Omnipod 5 Pod is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The Omnipod 5 Pod is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. SmartAdjust™ technology is intended for use with compatible integrated continuous glucose monitors (iCGM) and compatible to automatically increase, decrease, and pause delivery of insulin based on current and predicted glucose values. The Omnipod 5 SmartBolus Calculator is intended to calculate a suggested bolus dose based on user-entered carbohydrates, most recent sensor glucose value (or blood glucose reading if using fingerstick), rate of change of the sensor glucose (if applicable), insulin on board (IOB), and programmable correction factor, insulin to carbohydrate ratio, and target glucose value. Warning: SmartAdjust technology should NOT be used by anyone under the age of 2 years old. SmartAdjust technology should also NOT be used in people who require less than 5 units of insulin per day as the safety of the technology has not been evaluated in this population.
The Omnipod 5 System is NOT recommended for people who are unable to monitor glucose as recommended by their healthcare provider, are unable to maintain contact with their healthcare provider, are unable to use the Omnipod 5 System according to instructions, are taking hydroxyurea as it could lead to falsely elevated CGM values and result in over-delivery of insulin that can lead to severe hypoglycaemia, and do NOT have adequate hearing and/or vision to allow recognition of all functions of the Omnipod 5 System, including alerts, alarms, and reminders. Device components including the Pod, CGM transmitter, and CGM sensor must be removed before Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scan, or diathermy treatment. In addition, the Controller, phone control not available in international markets, should be placed outside of the procedure room. Exposure to MRI, CT, or diathermy treatment can damage the components.
Visit www.omnipod.com/safety for additional important safety information.
UK RISK STATEMENT HERE
Important Safety Information: Omnipod® 5 System safety and intended use information.
The Omnipod 5 System is indicated for use by individuals with type 1 diabetes mellitus in persons 2 years of age and older. The Omnipod 5 System is intended for single patient, home use and requires a prescription and/or ongoing supervision of a qualified healthcare professional. The Omnipod 5 System is compatible with the following U-100 insulins: NovoLog(R)/NovoRapid(R).Humalog®, and Admelog(R)/Insulin lispro Sanofi(R). The Omnipod 5 Pod is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The Omnipod 5 Pod is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. SmartAdjust™ technology is intended for use with compatible integrated continuous glucose monitors (iCGM) and compatible to automatically increase, decrease, and pause delivery of insulin based on current and predicted glucose values. The Omnipod 5 SmartBolus Calculator is intended to calculate a suggested bolus dose based on user-entered carbohydrates, most recent sensor glucose value (or blood glucose reading if using fingerstick), rate of change of the sensor glucose (if applicable), insulin on board (IOB), and programmable correction factor, insulin to carbohydrate ratio, and target glucose value. Warning: SmartAdjust technology should NOT be used by anyone under the age of 2 years old. SmartAdjust technology should also NOT be used in people who require less than 5 units of insulin per day as the safety of the technology has not been evaluated in this population.
The Omnipod 5 System is NOT recommended for people who are unable to monitor glucose as recommended by their healthcare provider, are unable to maintain contact with their healthcare provider, are unable to use the Omnipod 5 System according to instructions, are taking hydroxyurea as it could lead to falsely elevated CGM values and result in over-delivery of insulin that can lead to severe hypoglycaemia, and do NOT have adequate hearing and/or vision to allow recognition of all functions of the Omnipod 5 System, including alerts, alarms, and reminders. Device components including the Pod, CGM transmitter, and CGM sensor must be removed before Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scan, or diathermy treatment. In addition, the Controller, phone control not available in international markets, should be placed outside of the procedure room. Exposure to MRI, CT, or diathermy treatment can damage the components.
Visit www.omnipod.com/safety for additional important safety information.